HomeOwner SearchCategory Search
Visit USCOEuropean Journal of Pharmaceutics and Biopharmaceutics [Published: 2019-01-10. Issue: no. 134, January 2019]
Serial Registration
Copyright Title
European Journal of Pharmaceutics and Biopharmaceutics [Published: 2019-01-10. Issue: no. 134, January 2019]
Status
Published
on 19 Feb 2019
Year of Creation
2019
Copyright Claimant
International Association for Pharmaceutical Technology
Registration Number
TX0008726406
on 19 Feb 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008726406) dated 19 Feb 2019, pertains to an electronic file (eService) titled "European Journal of Pharmaceutics and Biopharmaceutics [Published: 2019-01-10. Issue: no. 134, January 2019]" created in 2019. The copyright holder is International Association for Pharmaceutical Technology, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to International Association for Pharmaceutical Technology.
Application Details
Registration Number
TX0008726406
Registration Date
2/19/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Elsevier
First Publication Nation
Netherlands
ISSN
0939-6411
Preexisting Material
Permissioned materials
Notes
Rights Note: permissions@elsevier.com
Copyright Local Holdings: no. 134, January 2019 Created 2019 Pub. 2019-01-10 Reg. 2019-03-08 TX0008726406 KABU
Material Matter Claimed Note: compilation, editing, text, figures
Statements
Application Title Statement: European Journal of Pharmaceutics and Biopharmaceutics
Author Statement: Elsevier employer for hire Domicile: Netherlands Citizenship: Netherlands Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.